Biogen has made Medidata Rave its primary clinical trial technology platform, continuing the shift in power in the eClinical market.

HHS has set up a challenge to identify ways in which blockchain can support privacy, security and scalability in health IT and research data.

Siemens Venture Capital has invested in Riffyn, a developer of R&D design software that is weeks away from introducing its first commercial product.

Genedata has landed a deal with Evotec, continuing a busy 18-month period in which it has signed up Bayer, Boehringer Ingelheim and Merck KGaA.

Pfizer has signed up to use clinical trial technologies from Oracle, a company it has stuck with as its Big Pharma peers have defected to Medidata.

ActiGraph has unveiled the CentrePoint Data Hub, a device capable of transferring data from its clinical-grade wearables to cloud repositories.

IBM is installing computing and storage infrastructure in Calgary as part of a 5-year pediatric genetic research collaboration.

CRO Ergomed has bolstered its IT capabilities by acquiring two German service providers that give it access to statistical analysis skills and an EDC system.